Characterization of the interaction between endostatin short peptide and VEGF receptor 3.

Characterization of the interaction between endostatin short peptide and VEGF receptor 3.

Item
http://www.wikidata.org/entity/Q40474234
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsThe dual role of tumor lymphatic vessels in dissemination of metastases and immune response developmentEndostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Nanotechnology in corneal neovascularization therapy--a reviewUnderstanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.
P2860

Characterization of the interaction between endostatin short peptide and VEGF receptor 3.

Item
http://www.wikidata.org/entity/Q40474234
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Characterization of the interaction between endostatin short peptide and VEGF receptor 3.
@en
type
label
Characterization of the interaction between endostatin short peptide and VEGF receptor 3.
@en
prefLabel
Characterization of the interaction between endostatin short peptide and VEGF receptor 3.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Characterization of the interaction between endostatin short peptide and VEGF receptor 3.
@en
P2093
P2860
P304
P31
P356
10.2174/092986612802084465
P433
P478
P577
P5875
P698
P932